In the second largest reported cohort, an association between THRβ expression and longer survival was observed, even after adjustment for age, tumor size, nodal status, chemotherapy, hormone therapy, radiotherapy, surgery, and ER status in a multi-variable model with a HR of 0.32 (95% CI 0.11–0.94), p  =  0.04. Here, THRB is linked to neoplasm.